Oxford BioMedica PLC (OXB) - Total Liabilities

Latest as of June 2025: GBX183.59 Million GBX ≈ $22.34K USD

Based on the latest financial reports, Oxford BioMedica PLC (OXB) has total liabilities worth GBX183.59 Million GBX (≈ $22.34K USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Oxford BioMedica PLC (OXB) cash conversion ratio to assess how effectively this company generates cash.

Oxford BioMedica PLC - Total Liabilities Trend (1996–2024)

This chart illustrates how Oxford BioMedica PLC's total liabilities have evolved over time, based on quarterly financial data. Check OXB asset liquidity ratio to evaluate the company's liquid asset resilience ratio.

Oxford BioMedica PLC Competitors by Total Liabilities

The table below lists competitors of Oxford BioMedica PLC ranked by their total liabilities.

Company	Country	Total Liabilities
Grande Asset Hotels and Property Public Company Limited BK:GRAND	Thailand	฿11.46 Billion
Sedania Innovator Bhd KLSE:0178	Malaysia	RM36.99 Million
Bytes Technology Ltd LSE:BYIT	UK	GBX342.52 Million
Swift Networks Group Ltd AU:SW1	Australia	AU$16.14 Million
Koszalinskie Przedsiebiorstwo Przemyslu Drzewnego SA WAR:KPD	Poland	zł77.34 Million
Morien Resources Corp V:MOX	Canada	CA$1.41 Million
Intanwijaya Internasional Tbk JK:INCI	Indonesia	Rp73.38 Billion

Liability Composition Analysis (1996–2024)

This chart breaks down Oxford BioMedica PLC's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Oxford BioMedica PLC (OXB) total market value.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	1.89	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	5.61	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.85	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Oxford BioMedica PLC's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Oxford BioMedica PLC (1996–2024)

The table below shows the annual total liabilities of Oxford BioMedica PLC from 1996 to 2024.

Year	Total Liabilities	Change
2024-12-31	GBX171.16 Million ≈ $20.82K	-1.92%
2023-12-31	GBX174.51 Million ≈ $21.23K	-22.09%
2022-12-31	GBX223.99 Million ≈ $27.25K	+348.95%
2021-12-31	GBX49.89 Million ≈ $6.07K	-29.91%
2020-12-31	GBX71.18 Million ≈ $8.66K	+50.50%
2019-12-31	GBX47.30 Million ≈ $5.75K	-39.10%
2018-12-31	GBX77.66 Million ≈ $9.45K	+31.06%
2017-12-31	GBX59.26 Million ≈ $7.21K	+33.68%
2016-12-31	GBX44.33 Million ≈ $5.39K	+8.23%
2015-12-31	GBX40.96 Million ≈ $4.98K	+280.43%
2014-12-31	GBX10.77 Million ≈ $1.31K	+126.84%
2013-12-31	GBX4.75 Million ≈ $577.45	-0.71%
2012-12-31	GBX4.78 Million ≈ $581.59	-42.58%
2011-12-31	GBX8.32 Million ≈ $1.01K	-40.71%
2010-12-31	GBX14.04 Million ≈ $1.71K	-38.88%
2009-12-31	GBX22.97 Million ≈ $2.80K	+15.73%
2008-12-31	GBX19.85 Million ≈ $2.42K	-32.09%
2007-12-31	GBX29.23 Million ≈ $3.56K	+436.53%
2006-12-31	GBX5.45 Million ≈ $662.86	+106.29%
2005-12-31	GBX2.64 Million ≈ $321.33	+19.77%
2004-12-31	GBX2.21 Million ≈ $268.28	+46.90%
2003-12-31	GBX1.50 Million ≈ $182.63	+19.13%
2002-12-31	GBX1.26 Million ≈ $153.31	-28.25%
2001-12-31	GBX1.76 Million ≈ $213.65	+31.04%
2000-12-31	GBX1.34 Million ≈ $163.04	+67.29%
1999-12-31	GBX801.00K ≈ $97.46	+66.88%
1998-12-31	GBX480.00K ≈ $58.40	+8.84%
1997-12-31	GBX441.00K ≈ $53.66	+250.00%
1996-12-31	GBX126.00K ≈ $15.33	0.00%
1996-09-30	GBX126.00K ≈ $15.33	--

About Oxford BioMedica PLC

LSE:OXB UK Biotechnology

Market Cap

$8.71 Million

GBX71.61 Billion GBX

Market Cap Rank

#27217 Global

#369 in UK

Share Price

GBX593.00

Change (1 day)

-1.17%

52-Week Range

GBX277.00 - GBX913.00

All Time High

GBX1634.00